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232 Abstractsaccompanied with decrease of Tb.Sp and SMI (p<0.05) compared to 0 Gy
group at 8 weeks post-operation (Figure3). The biomechanical results
showed that the maximum push-out force of the implants in the 0.5 Gy group
was significantly higher than that of 0 Gy group (Figure 4).
Conclusion: The results confirmed that local 0.5 Gy X-ray irradiation signif-
icantly improved the bone formation, trabecular bone microstructural
morphology around the implant, which significantly increased the integrity
of the implant with the bone tissue around it and may be beneficial for pre-
venting the aseptic loosening.
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Introduction: Poor muscle strength, balancing ability and low bone mineral
density (BMD) may cause fall and fragility fractures. It brings significant com-
plications, morbidities and high mortality. Low-magnitude high-frequency
vibration (LMHFV) treatment was previously shown to enhance muscle per-
formance and BMD. This study investigated the efficacy of long-term LMHFV
in reducing fall and fracture rates, as well as fracture risks of elderly.Methods: 710 female subjects aged 60 or above were recruited and ran-
domized into either control or treatment group on center-basis. The in-
clusion criteria included females aged 60 or above, active in the
community and without any osteoporosis treatment. Treatment group
subjects received LMHFV (35Hz, 0.3g) 20min/day, 5days/week for 18
months, while control group remained in habitual lifestyle. The occur-
rence of fall/fracture, muscle strength, balancing ability, quality of
life (QoL), BMD of hip & spine were assessed at baseline, 9 months,
and 18 months. Fifty randomly selected subjects further received 1
year of post-intervention follow-up to assess the residual effect of
LMHFV. Cox regression, cluster-adjusted t-test and independent t-test
were used for analysis.
Results: 18.6% treatment subjects reported falls while 28.7% in con-
trols; the incidence rate in treatment group was significantly lower
(adjusted IRRZ0.54, pZ0.001). 1.1% fracture rate was recorded in
treatment group, compared with 2.31% for controls. The muscle
strength of dominant and non-dominant legs were improved signifi-
cantly in treatment group (both p<0.001). In balancing ability test,
treatment group showed significant improvement in reaction time,
movement velocity and maximum excursion (p<0.001 for all). In the
high-compliance group (over 80%), BMD changes in the hip and spine
showed lower bone loss within the study period when compared with
the control group (pZ0.02 hip, 0.048 spine). One year after cessation
of intervention, improvement in muscle strength, reaction time and
movement velocity remained significant (p<0.05 to all) in vibration
group, when compared with baseline. Minimal adverse effects were
documented.
Conclusion: LMHFV significantly reduced fall rate by over 40%, which is the
key to prevent fragility fractures and other fall-related injuries. The benefi-
cial effects of LMHFV were also confirmed in improving muscle strength,
balancing ability and QoL as early as 9 months. One year after completion
of LMHFV, muscle performance remained significantly better than baseline
in vibration group, showing the sustainability of the effects from LMHFV.
All these findings were critical in pushing forward the application of LMHFV
in fall and fracture prevention in elderly.
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Background: Sarcopenia is an age-induced progressive loss of muscle mass
and strength, and associated with functional impairment in elderly. Low-
magnitude High-frequency vibration (LMHFV) treatment was previously
shown to improve balancing ability and muscle strength. This study was to
investigate the effectiveness of LMHFV on preventing loss of muscle strength
and mass.
Methods: 60 female subjects aged 60 or above were recruited and random-
ized into control or vibration group. Vibration group subjects received
LMHFV treatment (35Hz, 0.3g; gZgravitational acceleration) 20min/day,
5days/week for 9 months, while control group remained sedentary in normal
life style. Muscle strength, balancing ability, body composition, lower ex-
tremity functional scale and vibromyography (VMG) assessment were per-
formed at baseline and end-point (9-month).
Results: Significant enhancement of dominant and non-dominant leg muscle
strength was observed in the vibration group after 9 months of LMHFV
(p<0.001 andZ0.003 respectively). In the chair rising test assessing muscle
power and balancing ability, vibration group showed significantly shorter
time needed for sit-to-stand cycles than the control (pZ0.009). Significant
increase of the lower extremity functional scale was also observed in vibra-
tion group (pZ0.002). No significant findings were found in the body compo-
sition and VMG assessment; however, a distinguish trend of increasing lean
mass and VMG mean frequency were observed in vibration group. Also, min-
imal adverse effects were documented, and all subjects were well-tolerated
for LMHFV treatment.
Conclusion: The effect of LMHFV on enhancing muscle strength, balancing
ability and lower extremities functions were evident. LMHFV treatment
was well-tolerated by elderly as a daily exercise with no adverse effects.
The results support the use of LMHFV for lower extremity strengthening in
elderly.
